Tasca Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- December 10, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $52,000,000
Company Info
- Founders
- David Fisher, Milenko Cicmil, Xu Wu
- Company Description
- Tasca Therapeutics is a biotechnology company focused on discovering and developing small molecule inhibitors of auto-palmitoylated target proteins important in cancer. Its lead program, CP-383, is a first-in-class drug candidate, with preclinical activity against multiple cancer types.
- Market
- Cancer treatment
- Location
- Boston, Massachusetts, USA
- Coinvestors
- Regeneron Ventures, Cure Ventures, Invus Group